BIOMEA FUSION INC (BMEA) Stock Earnings & Estimates
USA - NASDAQ:BMEA - US09077A1060 - Common Stock
1.28 USD
-0.01 (-0.78%)
1.3 USD
+0.02 (+1.56%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A 104.46% | N/A 176.78% | |||||||
| EBITDA YoY % growth | -1.2M | -5.32M -343.33% | -41.42M -678.57% | -82.94M -100.24% | -124.62M -50.25% | -142.322M -14.20% | N/A 43.87% | N/A -19.26% | N/A -15.86% | N/A -16.43% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.2M | -5.33M -344.17% | -41.67M -681.80% | -83.63M -100.70% | -126.135M -50.83% | -144.07M -14.22% | N/A 41.80% | N/A -28.50% | N/A 0.36% | N/A -7.98% | N/A -3.14% | N/A 77.42% | N/A 326.55% | N/A 561.60% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -1.76 | -2.79 -58.52% | -3.46 -24.01% | -3.84 -10.98% | N/A 58.75% | N/A 12.98% | N/A -10.66% | N/A 22.21% | N/A 6.73% | N/A 107.37% | N/A 2,350.00% | N/A 210.20% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.24 70.30% | -0.28 65.57% | -0.30 42.00% | -0.31 -13.33% | -0.32 -31.45% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -17.096M 39.64% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.532M 48.35% | -16.83M 43.36% | -17.85M 16.10% | -18.36M 1.29% | -19.38M -24.78% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.27 70.33% | -0.26 | -0.01 | -3.47% |
| Q2 2025 Q2Q % growth | -0.51 50.49% | -0.54 | 0.03 | 5.77% |
| Q1 2025 Q2Q % growth | -0.80 26.61% | -0.62 | -0.18 | -28.20% |
| Q4 2024 Q2Q % growth | -0.81 17.35% | -0.94 | 0.13 | 13.79% |
| Q3 2024 Q2Q % growth | -0.91 -13.75% | -0.97 | 0.06 | 6.07% |
| Q2 2024 Q2Q % growth | -1.03 -47.14% | -1.09 | 0.06 | 5.70% |
| Q1 2024 Q2Q % growth | -1.09 -11.22% | -1.01 | -0.08 | -7.49% |
| Q4 2023 Q2Q % growth | -0.98 -13.95% | -0.87 | -0.11 | -12.83% |
| Q3 2023 Q2Q % growth | -0.80 -2.56% | -0.84 | 0.04 | 4.72% |
| Q2 2023 Q2Q % growth | -0.70 -18.64% | -0.89 | 0.19 | 21.58% |
| Q1 2023 Q2Q % growth | -0.98 -75.00% | -0.83 | -0.15 | -18.53% |
| Q4 2022 Q2Q % growth | -0.86 -68.63% | -0.83 | -0.03 | -3.60% |
| Q3 2022 Q2Q % growth | -0.78 -81.40% | -0.66 | -0.12 | -17.65% |
| Q2 2022 Q2Q % growth | -0.59 -78.79% | -0.61 | 0.02 | 3.92% |
| Q1 2022 Q2Q % growth | -0.56 -14.29% | -0.54 | -0.02 | -4.38% |
| Q4 2021 Q2Q % growth | -0.51 | -0.45 | -0.06 | -12.11% |
| Q3 2021 Q2Q % growth | -0.43 | -0.40 | -0.03 | -6.73% |
| Q2 2021 Q2Q % growth | -0.33 | -0.20 | -0.13 | -61.76% |
| Q1 2021 Q2Q % growth | -0.49 | -0.14 | -0.35 | -243.14% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 35.48% | 1.06% | 25.21% |
| Revenue | N/A | N/A | N/A | N/A |